Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
Sana’s stock soars on new cell therapy data; UniQure’s $75M offering
6 months ago
News Briefing
Novo Nordisk partners with Variant Bio; Aviceda raises $207M in Series C
6 months ago
News Briefing
I-Mab stops work on CD73; Citius to pursue ‘strategic’ options
6 months ago
News Briefing
Every FDA drug approval from 2024: Fewer nods, but long-awaited treatments cross the finish line
6 months ago
Pharma
FDA+
Hutchmed’s divestiture; Xgene reports Phase 2b win for non-opioid pain drug
6 months ago
News Briefing
Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round
6 months ago
News Briefing
PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal
6 months ago
Deals
News Briefing
Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug
6 months ago
News Briefing
The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma
6 months ago
Special
Pharma
Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger
6 months ago
News Briefing
Affimed’s early lung cancer data disappoint; Indapta's $22M round
6 months ago
News Briefing
Candid inks three T cell engager deals; PepGen trial put on hold
6 months ago
News Briefing
Eisai subsidiary nabs Japan rights for schizophrenia drug; Novavax's $50M milestone
6 months ago
News Briefing
Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site
7 months ago
News Briefing
BenevolentAI restructures; Cimeio, Kyowa ink cell therapy deal
7 months ago
News Briefing
CervoMed’s Phase 2 miss; NICE to cover Santhera’s Duchenne drug
7 months ago
News Briefing
Enanta's mid-stage win in pediatric RSV; Carisma to lay off 34% of staff
7 months ago
News Briefing
Teva to divest business venture in Japan; Layoffs at Rome Therapeutics
7 months ago
News Briefing
UK to limit access to Lilly’s Zepbound; VivaVision’s positive Phase 2
7 months ago
News Briefing
AstraZeneca's new EVP of international amid China investigation; Janux’s $300M offering
7 months ago
News Briefing
BMS inks deal with AI Proteins; Terns’ early-stage leukemia data
7 months ago
News Briefing
Senti Bio’s Phase 1 CAR-NK data; Allink raises $42M
7 months ago
News Briefing
Recursion reduces workforce; Oxford Nanopore teams up with UK Biobank
7 months ago
News Briefing
Aviceda aims to raise $200M; Nerviano gets back rights to PARP1 inhibitor
7 months ago
News Briefing
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page